Skip to main content

Response of coronary arteries to nitrates, the EDRF-donor SIN-1, and calcium antagonists

  • Conference paper
Endothelial Mechanisms of Vasomotor Control
  • 58 Accesses

Summary

Intracoronary drug administration is an important tool to study coronary effects without interaction of systemic effects. The difficult methodological aspects and the results of clinical trials in which the effects of vasodilating drugs were evaluated with respect to coronary dilatation are reviewed.

Major (coronary substrate, study design) and minor (measuring devices, methods of evaluation) methodological problems make it difficult to precisely evaluate pharmacological effects such as dose-response relationship, duration of action, and selective responses, and to compare the effects of different drugs. From a clinical point of view, knowledge of the maximal effect (EDmax) in coronary stenoses and the duration of action is essential.

NO-donors tend to act stronger than CA-channel blockers which may be attributable to their different modes of action. Among those NO-donors investigated, SIN-1 showed stronger effects than nitroglycerin. Only with SIN-1 were maximal effects obviously achieved. The additional administration of nitroglycerin or nisoldipine never led to a more prominent dilatation.

In coronary stenoses, the underlying morphology causes a wider range of responses than is seen in normal segments: deendothelialized stenoses with high coronary tone show a larger dilatation, while fully sclerotic stenoses may not react.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berkenboom GM, Unger P, Jottrand M, Loiseau J, Pype F, Degre SG (1987) Exercise-induced angina alleviated by intracoronary SIN-1. Cardiology 74:427–435

    Article  PubMed  CAS  Google Scholar 

  2. Bernauer R, Schulz W, Kober G (1986) Auswirkungen von intrakoronaren Nitroglyceringaben auf die poststenotische Gefäß weite vor und nach transluminaler koronarer Angioplastie. Z Kardiol 75:19–26

    PubMed  CAS  Google Scholar 

  3. Bonzel T, Wollschläger H, Löllgen H (1985a) Erweiterung der epikardialen Koronargefäße durch intravenöses Diltiazem bei Patienten mit koronarer Herzkrankheit. Z Kardiol 74:238–244

    PubMed  CAS  Google Scholar 

  4. Bonzel T (1985 b) Interner Prüfbericht Cassella AG. Protokoll-Nr. 84-0276-091

    Google Scholar 

  5. Bonzel T, Hasenfuß G, Wollschläger H, Hug J, Just H (1988) Koronardilatierende Langzeitwirkung nach intravenöser Bolusinjektion von Molsidomin. Z Kardiol 77 (Suppl 1)

    Google Scholar 

  6. Brown BG, Bolson E, Frimer M, Dodge HT (1977) Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation 55:329–337

    PubMed  CAS  Google Scholar 

  7. Brown BG (1983) Dilation of coronary artery stenosis: A major mechanism of the effect of nitrates. Z Kardiol (Suppl 3) 72:77–81

    PubMed  Google Scholar 

  8. Busse R, Pohl U, Mülsch A, Bassenge E (1989) Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc Pharmacol 14 (Suppl 11)81–85

    Google Scholar 

  9. Chew CYC, Brown BG, Singh BN, Hecht HS (1980) Mechanism of action of verapamil in ischemic heart disease: observations on changes in systemic and coronary hemodynamics and coronary vasomobility. Clin Invest Med 3:151–158

    PubMed  CAS  Google Scholar 

  10. Dhurandhar RW, Watt DL, Silver MD, Trimble AS, Adelman AG (1972) Prinzmetal’s variant form of angina with artriographic evidence of coronary arterial spasm. Am J Cardiol 30:902–905

    Article  PubMed  CAS  Google Scholar 

  11. Dirschinger J, Fleck E, Redl A, Rudolph W (1983) Regionale Myokarddurchblutung unter der Wirkung von Nifedipin in Abhängigkeit von Lumenänderung im Stenosebereich und Kollateralversorgung. Z Kardiol (Suppl 1) 72:14

    Google Scholar 

  12. Feelisch M, Noack EA (1987) Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J of Pharmacol 139:19–30

    Article  CAS  Google Scholar 

  13. Feldman RL, Pepine CJ, Conti CR (1981) Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 64:324–333

    Article  PubMed  CAS  Google Scholar 

  14. Ganz W, Markus HS (1972) Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46:880–889

    PubMed  CAS  Google Scholar 

  15. Gensini GG, Di Giorgi S, Murad-Netto S, Black A (1962) Arteriographic demonstration of coronary artery spasm and its release after the use of a vasodilator in a case of angina pectoris and in the experimental animal. Angiology 13:550–553

    Article  PubMed  CAS  Google Scholar 

  16. Jost S, Reil GH, Knop I, Rafflenbeul W, Gulba D, Hecker H, Frombach R, Lichtlen P (1989) Vasodilatatorische Effekte von SIN-1-Wirksamkeit zusätzlicher Nitroglycerin-Gaben. Perfusion 3

    Google Scholar 

  17. Jost S, Auricchio A, Rafflenbeul W, Gulba D, Frombach R, Hecker H, Lichtlen P (1990) Maximale Dilatation epikardialer Koronararterien mit Calcium-Antagonisten und/oder Nitroverbindungen? Z Kardiol 79 (Suppl 1):151

    Google Scholar 

  18. Kaltenbach M, Schulz W, Kober G (1979) Effects of nifedipine after intravenous and intracoronary administration. Am J Cardiol 44:832–838

    Article  PubMed  CAS  Google Scholar 

  19. Karsch KK, Niemczyk P, Voelker W, Seipel L (1984) Dynamik der kritischen Stenose bei Patienten mit instabiler Angina pectoris. Z Kardiol 73:552–559

    PubMed  CAS  Google Scholar 

  20. Kober G, Spahn G, Becker HJ, Kaltenbach M (1974) Weite und Querschnittsfläche der großen epikardialen Koronararterien bei Herzmuskelhypertrophie. Z Kardiol 63:297–310

    PubMed  CAS  Google Scholar 

  21. Maseri A, Mimmo R, Chierchia S, Marchesi C, Pesola A, L’Abbate A (1975) Coronary artery spasm as a cause of acute myocardial ischemia in man. Chest 68:625–633

    Article  Google Scholar 

  22. Maseri A, Pesola A, Marzilli M, Seven S, Parodi O, L’Abbate A, Ballestra AM, Maltinti G, De Nes DM, Biagini A (1977) Coronary vasospasm in angina pectoris. Lancet 1:713–717

    Article  PubMed  CAS  Google Scholar 

  23. Oliva PB, Potts DE, Pluss RG (1973) Coronary arterial spasm in prinzmetal angina. N Engl J Med 288:745–751

    Article  PubMed  CAS  Google Scholar 

  24. Osier W (1910) The lumleian lectures on angina pectoris. Lancet I:697–702

    Google Scholar 

  25. Parkinson J, Bedford DE (1931) Electrocardiographic changes during brief attacks of angina pectoris. Lancet I:15–19

    Article  Google Scholar 

  26. Peretz DI (1961) Variant angina pectoris of prinzmetal. Canad Med Ass J 85:1101–1102

    PubMed  CAS  Google Scholar 

  27. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N (1959) Angina pectoris. A variant form of angina pectoris. Am J Med 27:375–388

    Article  PubMed  CAS  Google Scholar 

  28. Rafflenbeul W, Lichtlen PR (1983 a) Release of residual vascular tone in coronary artery stenoses with nifedipine and glyceril trinitrate. In: Kaltenbach M, Neufeld HN (eds) 5th International Adalat symposium. New therapy of ischemic heart disease and hypertension. Experta Medica Amsterdam/Oxford/Princeton, pp 300-308

    Google Scholar 

  29. Rafflenbeul W, Lichtlen PR (1983b) Quantitative coronary angiography: evidence of a sustained increase in vascular smooth muscle tone in coronary artery stenoses. Z Kardiol 72 (Suppl 3):87–91

    PubMed  Google Scholar 

  30. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JCH, den Boer A, Hugenholtz PG (1985) Assessment of short-, medium-and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71:280–288

    Article  PubMed  CAS  Google Scholar 

  31. Schulz W, Kober G, Bamberg E, Kaltenbach M (1978) Kardiale und periphere Effekte von Nifedipin. Z Kardiol 67:196

    Google Scholar 

  32. Schulz W, Wendt T, Scherer D, Kober G (1983a) Weitenänderungen epikardialer Koronararterien und Koronarstenosen nach intrakoronarer Gabe von Sin-1, einem Molsidomin-Metaboliten. Z Kardiol 72:404–409

    PubMed  CAS  Google Scholar 

  33. Schulz W, Anderten WV, Reiber JHC, Bernauer R, Kaltenbach M, Kober G (1983b) Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin. Z Kardiol 72 (Suppl 3):82–86

    PubMed  Google Scholar 

  34. Schulz W, Wendt T, Kaltenbach M, Kober G (1983 c) Active and passive changes in coronary artery diameters after vasodilation. In: Kaltenbach M, Neufeld HN (eds) 5th International Adalat symposium. New therapy of ischemic heart disease and hypertension. Experta Medica Amsterdam/Oxford/Princeton, pp 309-317

    Google Scholar 

  35. Schulz W, Kaltenbach M, Kober G (1983 d) Chronotropic response after injection of nifedipine into the sinus node artery in man. In: Kaltenbach M, Neufeld HN (eds) 5th International Adalat symposium. New therapy of ischemic heart disease and hypertension. Experta Medica Amsterdam/Oxford/Princeton, pp 322-326

    Google Scholar 

  36. Schulz W, Kober G, Bernauer R, Kaltenbach M (1985) Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine. Am Heart J 109:694–699

    Article  PubMed  CAS  Google Scholar 

  37. Schulz W, Kaufhold A, Kaltenbach M, Kober G (1990) Der „vasospastische“ Ruheherzschmerz. Herz + Gefäße 10:416–421

    Google Scholar 

  38. Sebening H, Sauer E (1983) Beeinflussung der Koronararterien und Hämodynamik durch Gallopamil. In: Kaltenbach M, Hopf R (Hrsg) Springer-Verlag Berlin, S. 117-119

    Google Scholar 

  39. Serruys PW, Steward R, Booman F, Michels R, Reiber JHC, Hugenholtz PG (1980) Can unstable angina pectoris be due to increased coronary vasomotor tone? Eur Heart J 1 (Suppl B): 71–85

    PubMed  CAS  Google Scholar 

  40. Serruys PW, Deckers JW, Luijten HE, Reiber JHC, Tijssen JGP, Chadha D, Hugenholtz PG (1987) Long-acting coronary vasodilatory action of the molsidomine metabolite SIN-1: a quantitative angiographie study. Eur Heart J 8:263–270

    PubMed  CAS  Google Scholar 

  41. Siegel M, Feil H (1931) Electrocardiographic studies during attacks of angina pectoris and of other paroxysmal pain. J Clin Invest 10:795–806

    Article  PubMed  CAS  Google Scholar 

  42. Sobolski J, Vandermoten P, Stoupel E, Berkenboom G, Degre S (1985) The new long-acting coronary dilator molsidomine and its metabolite SIN-1. Am Heart J 109:700–703

    Article  PubMed  CAS  Google Scholar 

  43. Wilson FN, Johnston FD (1941) The occurrence in angina pectoris of electrocardiographic changes similar in magnitude and in kind to those produced by myocardial infarction. Am Heart J 22:64–74

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Schulz, W., Kober, G. (1991). Response of coronary arteries to nitrates, the EDRF-donor SIN-1, and calcium antagonists. In: Drexler, H., Zeiher, A.M., Bassenge, E., Just, H. (eds) Endothelial Mechanisms of Vasomotor Control. Steinkopff. https://doi.org/10.1007/978-3-642-72461-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72461-9_23

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-72463-3

  • Online ISBN: 978-3-642-72461-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics